CLL
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
July, 2024
July 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Jun
CLL
Jul 2, 2024, 04:51 |
Insight
Frequent IgG testing in CLL and NHL showed reduced rates of infections - ASH
ASH shared a post on X: "A new study in Blood Advances find that patients…
Jul 1, 2024, 19:24 |
Insight
Léa Ikhlef: The use of extracellular vesicles as a communication tool by TAMS in CLL
Léa Ikhlef, Postdoctoral researcher at Léon Bérard Center, shared on LinkedIn: “I'm glad to share…
Jun 24, 2024, 02:19 |
Insight
Nitin Jain: Pirtobrutinib Venetoclax and Obinutuzumab in First-Line treatment for CLL
Nitin Jain shared on X: . "Delighted…
Jun 12, 2024, 14:46 |
Insight
Elisa ten Hacken: Finally, the seminars in the Hematology Review Series on CLL have been published
Elisa ten Hacken, Assistant Professor at Weill Cornell Medicine, shared a post on X: "Excited…
Jun 11, 2024, 14:59 |
Insight
Timos Papagatsias: EHA24 is expected to be one of the most exciting EHA conferences to-date!
Timos Papagatsias, CEO of LucidQuest shared a post on LinkedIn: “EHA24 is fast approaching and…
Jun 10, 2024, 16:08 |
Blog
It was great to catch up with Mazyar Shadman at ASCO24 - VJHemOnc
VJHemOnc shared a post on X: "It was great to catch up with Mazyar Shadman at…
May 22, 2024, 01:53 |
Insight
Nitin Jain: Looking forward to presenting phase 2 trial of frontline treatment for patients with CLL at EHA 2024
Nitin Jain, Professor of the Department of Leukemia at MD Anderson Cancer Center, shared on…
May 10, 2024, 11:47 |
Blog
Andrew M. Evens: Thank you for the invite to the 1st HemeOnc Pulse LIVE
Andrew M. Evens, Deputy Director for Clinical Services at Rutgers Cancer Institute, recently shared on…
May 2, 2024, 09:25 |
Blog
Rahul Gosain: HemeSeries with Nitin Jain
Rahul Gosain, Director of Regional Infusion Services at Wilmot Cancer Institute, shared a post on LinkedIn: "HemeSeries:…
Apr 29, 2024, 00:16 |
Insight
Kate Cwynarski: Wonderful talk by Philippe Gaulard
Kate Cwynarski, Haematogist-Oncologist in Lymphoma and CLL at University College London Hospital, shared on X/Twitter:…
Mar 19, 2024, 03:44 |
Drugs
Nitin Jain: The U.S. FDA approves lisocabtagene maraleucel for adults with relapsed or refractory CLL or SLL
Nitin Jain, The Director of the Leukemia CAR-T Program at the MD Anderson Cancer Center,…
Dec 5, 2023, 12:57 |
Drugs
Toby Eyre: Big news in CLL
Toby Eyre, CLL specialist at Oxford University Hospitals, announced on X/Twitter: "Big news in CLL.…
Oct 15, 2023, 15:13 |
Blog
John Byrd: So great to be together with these great friends who have a passion for developing new therapies and caring for patients with CLL.
John Byrd, Chair at the Department of Internal Medicine, University of Cincinnati College of Medicine, shared on…
Aug 31, 2023, 18:42 |
Blog
Piers Blombery: Well done to Martin Vu for publishing this important health economic analysis on the cost-effectiveness of TP53/IGHV molecular testing in chronic lymphocytic leukemia in Australia.
All:
14
Posts:
1 - 100
OncoDaily at ASCO 2024: OncoDaily Party, Yvonne Award and much more
Tedros Adhanom Ghebreyesus received University of Nicosia’s Honorary Doctorate
Lisa A. Lacasse: A major milestone towards Congress passing the bipartisan MCED Act
July is Sarcoma Awareness Month
25 Posts You Should Not Miss From ESMOGI24!
Facebook
RSS Feed
Twitter
Linkedin
Youtube